Adrienne S Allen1, Thomas D Sequist. 1. North Shore Physicians Group, 104 Endicott Street, Suite 104, Danvers, MA 01923, USA. aallen0@partners.org
Abstract
BACKGROUND: Most physician offices do not transmit orders for medication discontinuation to the pharmacy, creating the potential for errors in dispensing of previously prescribed medications. Electronic health records offer the potential to assess this patient safety concern. OBJECTIVE: To assess the frequency of and potential patient harm associated with pharmacy dispensing of discontinued medications in the ambulatory setting. DESIGN: Retrospective cohort study. SETTING: Multispecialty group practice in eastern Massachusetts using an electronic health record. PATIENTS: 30 406 adult patients with an electronic discontinuation order for antihypertensive, antiplatelet, anticoagulant, oral hypoglycemic, and statin medications between November 2008 and October 2009. MEASUREMENTS: Dispensing of discontinued medications within 12 months and associated potential patient harm. RESULTS: Among 83 902 targeted medications that were electronically discontinued, 1218 (1.5% [95% CI, 1.4% to 1.5%]) were subsequently dispensed by the pharmacy a mean of 1.0 (SD, 0.3) time during the 12-month follow-up. Among the top 10 most frequently electronically discontinued medications, the rate of subsequent dispensing by a pharmacy ranged from 0.9% for metformin to 2.5% for metoprolol. Manual chart review of 416 medication-dispensing events that were predefined as high risk according to an automated algorithm identified potential harm in 50 (12%) cases, including clinical reactions (n = 18), laboratory abnormalities (n = 17), duplicated medication classes dispensed (n = 8), and potential allergic reactions (n = 7). LIMITATION: Information on pharmacy dispensing was available for only 52% of medication orders. CONCLUSION: The dispensing of discontinued medications represents an important ambulatory patient safety concern. Electronic health records should be used to facilitate better communication between providers and pharmacies and improve medication safety. PRIMARY FUNDING SOURCE: National Institutes of Health.
BACKGROUND: Most physician offices do not transmit orders for medication discontinuation to the pharmacy, creating the potential for errors in dispensing of previously prescribed medications. Electronic health records offer the potential to assess this patient safety concern. OBJECTIVE: To assess the frequency of and potential patient harm associated with pharmacy dispensing of discontinued medications in the ambulatory setting. DESIGN: Retrospective cohort study. SETTING: Multispecialty group practice in eastern Massachusetts using an electronic health record. PATIENTS: 30 406 adult patients with an electronic discontinuation order for antihypertensive, antiplatelet, anticoagulant, oral hypoglycemic, and statin medications between November 2008 and October 2009. MEASUREMENTS: Dispensing of discontinued medications within 12 months and associated potential patient harm. RESULTS: Among 83 902 targeted medications that were electronically discontinued, 1218 (1.5% [95% CI, 1.4% to 1.5%]) were subsequently dispensed by the pharmacy a mean of 1.0 (SD, 0.3) time during the 12-month follow-up. Among the top 10 most frequently electronically discontinued medications, the rate of subsequent dispensing by a pharmacy ranged from 0.9% for metformin to 2.5% for metoprolol. Manual chart review of 416 medication-dispensing events that were predefined as high risk according to an automated algorithm identified potential harm in 50 (12%) cases, including clinical reactions (n = 18), laboratory abnormalities (n = 17), duplicated medication classes dispensed (n = 8), and potential allergic reactions (n = 7). LIMITATION: Information on pharmacy dispensing was available for only 52% of medication orders. CONCLUSION: The dispensing of discontinued medications represents an important ambulatory patient safety concern. Electronic health records should be used to facilitate better communication between providers and pharmacies and improve medication safety. PRIMARY FUNDING SOURCE: National Institutes of Health.
Authors: Samantha I Pitts; Noah Barasch; Andrew T Maslen; Bridgette A Thomas; Leonard P Dorissaint; Krista G Decker; Sadaf Kazi; Yushi Yang; Allen R Chen Journal: Appl Clin Inform Date: 2019-05-22 Impact factor: 2.342
Authors: Yuze Yang; Stacy Ward-Charlerie; Nitu Kashyap; Richelle DeMayo; Thomas Agresta; James Green Journal: J Am Med Inform Assoc Date: 2018-11-01 Impact factor: 4.497
Authors: Taylor L Watterson; Jamie A Stone; Roger Brown; Ka Z Xiong; Anthony Schiefelbein; Edmond Ramly; Peter Kleinschmidt; Michael Semanik; Lauren Craddock; Samantha Pitts; Taylor Woodroof; Michelle A Chui Journal: J Am Med Inform Assoc Date: 2021-07-14 Impact factor: 4.497
Authors: Taylor L Watterson; Jamie A Stone; Aaron Gilson; Roger Brown; Ka Z Xiong; Anthony Schiefelbein; Edmond Ramly; Peter Kleinschmidt; Michael Semanik; Lauren Craddock; Samantha I Pitts; Taylor Woodroof; Michelle A Chui Journal: BMC Med Inform Decis Mak Date: 2022-02-25 Impact factor: 2.796
Authors: Taylor L Watterson; Sara E Hernandez; Jamie A Stone; Aaron M Gilson; Edmond Ramly; Michelle A Chui Journal: Explor Res Clin Soc Pharm Date: 2022-01-25